Poisoning with equine phenylbutazone in a racetrack worker.

The research article discusses a case of Phenylbutazone poisoning in a racetrack worker who ingested the drug to treat a toothache, resulting in severe health issues including seizures, coma, respiratory and renal failures, which were successfully managed with intensive care and hemodialysis over six weeks.

Introduction and Case Background

• The research focuses on a case study of a 24-year-old racetrack worker who ingested equine phenylbutazone, a potent nonsteroidal anti-inflammatory drug (NSAID) often used by veterinarians to treat inflammation and pain in horses.
• The worker, who was suffering from a toothache, intentionally consumed large amounts of this drug over a 24-hour period, resulting in severe poisoning and adverse health effects.

Analyzed Adverse Effects

• The individual experienced a range of severe health issues as a result of phenylbutazone toxicity. These included grand mal seizures (a type of seizure involving a loss of consciousness and violent muscle contractions), a state of deep unconsciousness (coma), low blood pressure (hypotension), failures of the respiratory and renal systems, and liver injury (hepatic injury).
• A serum phenylbutazone concentration test was conducted roughly eight hours after the worker arrived for medical assistance, revealing a level of 900 micrograms per milliliter. This was a significantly high concentration, further highlighting the severity of the condition.

Treatment and Recovery

• The research highlights the critical role of intensive supportive care and repeated hemodialysis throughout the six-week recovery period.
• Despite the major challenges posed by the high toxicity of phenylbutazone and the severe adverse health effects, the worker made a recovery after receiving the described treatment, underlying the effectiveness of the applied healthcare methods.

Overall Significance

• The use of phenylbutazone in humans is rare due to its high potential for causing adverse effects and the availability of newer, safer drugs. Thus, this case study serves as an alarming example of the severe health implications associated with the misuse or overconsumption of such potent drugs.
• This research also demonstrates the importance of adequate healthcare provision and the need for more effective controls on potent veterinary drugs to prevent their misuse.